BRPI1100013A2 - microesfera, métodos de preparar microesferas, de embolização em um paciente, e de gerenciar ou tratar uma doença dependente da angiogênese em um paciente - Google Patents

microesfera, métodos de preparar microesferas, de embolização em um paciente, e de gerenciar ou tratar uma doença dependente da angiogênese em um paciente

Info

Publication number
BRPI1100013A2
BRPI1100013A2 BRPI1100013A BRPI1100013A BRPI1100013A2 BR PI1100013 A2 BRPI1100013 A2 BR PI1100013A2 BR PI1100013 A BRPI1100013 A BR PI1100013A BR PI1100013 A BRPI1100013 A BR PI1100013A BR PI1100013 A2 BRPI1100013 A2 BR PI1100013A2
Authority
BR
Brazil
Prior art keywords
patient
embolization
microsphere
angiogenesis
managing
Prior art date
Application number
BRPI1100013A
Other languages
English (en)
Inventor
Barbara De Gioannis
James Krom
Philippe Reb
Pierre Marion
Original Assignee
Biosphere Medical Inc
Biosphere Medical S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosphere Medical Inc, Biosphere Medical S A filed Critical Biosphere Medical Inc
Publication of BRPI1100013A2 publication Critical patent/BRPI1100013A2/pt
Publication of BRPI1100013B1 publication Critical patent/BRPI1100013B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/52—Amides or imides
    • C08F20/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F20/56—Acrylamide; Methacrylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/44—Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246—Intercrosslinking of at least two polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/24—Homopolymers or copolymers of amides or imides
    • C08L33/26—Homopolymers or copolymers of acrylamide or methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09H—PREPARATION OF GLUE OR GELATINE
    • C09H9/00—Drying of glue or gelatine
    • C09H9/04—Drying of glue or gelatine in the form of granules, e.g. beads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/504—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of blood vessels, e.g. by angiography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
    • C08J2333/24—Homopolymers or copolymers of amides or imides
    • C08J2333/26—Homopolymers or copolymers of acrylamide or methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00—Characterised by the use of proteins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2489/00—Characterised by the use of proteins; Derivatives thereof
    • C08J2489/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08J2489/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Neurosurgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI1100013-9A 2010-01-27 2011-01-26 microesfera, uso da mesma, e, método de preparar microesferas BRPI1100013B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US46074210P 2010-01-27 2010-01-27
EP10305093.6A EP2351779B1 (en) 2010-01-27 2010-01-27 Microspheres and method of making the microspheres
EP10305093.6 2010-01-27
US61/460,742 2010-01-27
PCT/EP2011/051059 WO2011092196A1 (en) 2010-01-27 2011-01-26 Microspheres useful for therapeutic vascular embolization

Publications (2)

Publication Number Publication Date
BRPI1100013A2 true BRPI1100013A2 (pt) 2016-05-03
BRPI1100013B1 BRPI1100013B1 (pt) 2020-10-13

Family

ID=42338175

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1100013-9A BRPI1100013B1 (pt) 2010-01-27 2011-01-26 microesfera, uso da mesma, e, método de preparar microesferas

Country Status (7)

Country Link
US (3) US20110182998A1 (pt)
EP (1) EP2351779B1 (pt)
JP (4) JP2012511055A (pt)
KR (1) KR101297500B1 (pt)
CN (1) CN102232098B (pt)
BR (1) BRPI1100013B1 (pt)
WO (1) WO2011092196A1 (pt)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
US7338657B2 (en) * 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
EP1274472A2 (en) 2000-03-20 2003-01-15 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
DE01918975T1 (de) 2000-03-24 2006-04-13 Biosphere Medical, Inc., Rockland Mikrokügelchen zur aktiven Embolisierung
KR20140090270A (ko) 2005-05-09 2014-07-16 바이오스피어 메디칼 에스.에이. 마이크로스피어 및 비이온성 조영제를 사용하는 조성물 및 방법
WO2007090127A2 (en) 2006-01-30 2007-08-09 Surgica Corporation Compressible intravascular embolization particles and related methods and delivery systems
JP2010500917A (ja) 2006-06-15 2010-01-14 マイクロベンション， インコーポレイテッド 膨張性ポリマーで構成される塞栓形成デバイス
AU2008345590B2 (en) 2007-12-21 2014-10-30 Microvention, Inc. Hydrogel filaments for biomedical uses
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
CN102143996A (zh) * 2008-10-30 2011-08-03 大卫·刘 微球形多孔可生物相容支架及制造该支架的方法和装置
BRPI1014645B1 (pt) 2009-04-30 2020-07-07 Technip France método e sistema para compartilhar linhas de amarração
CN102791183B (zh) 2009-10-26 2015-07-08 微排放器公司 由可膨胀的聚合物构成的栓塞装置
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
EP2351779B1 (en) * 2010-01-27 2019-04-24 Biosphere Medical, Inc. Microspheres and method of making the microspheres
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
WO2013158781A1 (en) 2012-04-18 2013-10-24 Microvention, Inc. Embolic devices
AU2013274199B2 (en) 2012-06-14 2016-08-11 Microvention, Inc. Polymeric treatment compositions
CN102727913B (zh) * 2012-07-02 2013-11-06 四川大学 一种高标记率的碘标记明胶微球的制备方法
WO2014062696A1 (en) 2012-10-15 2014-04-24 Microvention, Inc. Polymeric treatment compositions
US9572700B1 (en) * 2013-03-08 2017-02-21 Endobar Solutions Llc Percutaneous endovasular treatment for obesity by selectively delivering particles into the distal portion of the left gastric artery
WO2014159759A1 (en) * 2013-03-13 2014-10-02 Biosphere Medical, Inc. Compositions and associated methods for radioisotope-binding microparticles
US20140335020A1 (en) * 2013-05-13 2014-11-13 King Faisal Specialist Hospital and Research Centr Composition and method of making the novel polymer gel for use in dosimeter
US20150050214A1 (en) * 2013-08-13 2015-02-19 King Faisal Specialist Hospital And Research Centre Composition and method of making the novel 3d polymer gel for use in radiation treatment planning
JP6537969B2 (ja) * 2013-09-06 2019-07-03 テルモ株式会社 シリンジ用外筒及び射出成形用金型
AU2014321277B2 (en) 2013-09-19 2017-07-20 Terumo Corporation Polymer particles
EP3046956B1 (en) 2013-09-19 2019-08-28 Microvention, Inc. Polymer films
CN103550834B (zh) * 2013-10-25 2015-07-15 北京大学 一种栓塞材料组合物及其制备方法和用途
EP3065719A4 (en) 2013-11-08 2017-08-09 Terumo Corporation Polymer particles
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
EP3137124B1 (en) 2014-04-29 2019-01-09 Microvention, Inc. Polymers including active agents
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
JP2016029372A (ja) * 2014-07-18 2016-03-03 サントリーホールディングス株式会社 Ｎｍｒを用いて酒類を高精度に分析する方法
JP6362137B2 (ja) * 2014-09-10 2018-07-25 学校法人神戸学院 新規な水性液状塞栓組成物
PL3264997T3 (pl) 2015-03-02 2019-07-31 Accurate Medical Therapeutics Ltd. Cewniki z otworami bocznymi do modyfikowania i podawania zawiesin pacjentowi
WO2016154592A1 (en) 2015-03-26 2016-09-29 Microvention, Inc. Embiolic particles
US10071181B1 (en) 2015-04-17 2018-09-11 Teleflex Innovations S.À.R.L. Resorbable embolization spheres
KR101667328B1 (ko) * 2015-05-07 2016-10-18 주식회사 엔게인 수화겔 입자 및 복합 색전물질
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
JP6921116B2 (ja) 2016-05-04 2021-08-18 アキュレイト メディカル セラピューティクス リミテッド スリットパターンを有する塞栓マイクロカテーテルヘッド
US10368874B2 (en) 2016-08-26 2019-08-06 Microvention, Inc. Embolic compositions
EP3520824A4 (en) * 2016-09-27 2020-04-29 Sogang University Research Foundation COMPOSITION FOR THE HEPATIC ARTERIAL CHEMOEMBOLISATION USING HUMAN SERUM ALUMINUM NANOPARTICLES WITH AN ANTI-DRIVING AGENT AND METHOD FOR THE PRODUCTION THEREOF
EP3518983B1 (en) 2016-09-28 2024-04-24 Terumo Corporation Polymer particles
CN108686258A (zh) * 2017-04-10 2018-10-23 南京慧联生物科技有限公司 互穿网络栓塞微球及其制备方法
CN116173284B (zh) * 2017-07-13 2025-09-19 瓦里安医疗系统公司 栓塞微球
JP7362598B2 (ja) 2017-10-09 2023-10-17 マイクロベンション インコーポレイテッド 放射性液体塞栓物質
JP7364193B2 (ja) 2017-11-02 2023-10-18 アキュレイト メディカル セラピューティクス リミテッド 内蔵フィルタを有する塞栓術用カテーテル
CN109134768B (zh) * 2018-08-28 2021-03-26 黑龙江吉地油田服务股份有限公司 一种纳米级聚合物微球及其制备方法
WO2020234889A1 (en) 2019-05-23 2020-11-26 Accurate Medical Therapeutics Ltd. Embolization catheter for reflux free delivery of microspheres
CN117598506A (zh) 2019-09-12 2024-02-27 努利希尔有限公司 受控释放的核-壳粒子及包含其的悬浮液
KR102437252B1 (ko) * 2019-12-20 2022-08-30 한양대학교 에리카산학협력단 Nmr 분석을 기반으로 한 마이크로캡슐의 내구성 및 분해성 평가 방법
WO2021206440A1 (ko) * 2020-04-09 2021-10-14 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
CN111893087B (zh) * 2020-08-13 2022-10-11 北京臻惠康生物科技有限公司 一种宫内膜采集装置及宫内膜干细胞收获方法
CN114106252B (zh) * 2021-12-13 2022-11-08 科睿驰（深圳）医疗科技发展有限公司 显色栓塞微球及其制备方法
CN115078592B (zh) * 2022-07-15 2024-01-23 广东广纳安疗科技有限公司 丙烯酰胺类单体的检测方法及其应用
CN115252876B (zh) * 2022-07-27 2023-11-24 青岛大学 一种单分散发光显影载药四合一栓塞微球及其制备方法
CN115737895B (zh) * 2022-11-10 2024-08-27 江南大学 一种用于抗肝癌的磁性栓塞微球及其制备方法与应用
CN116617445B (zh) * 2023-07-26 2023-10-17 海杰亚（北京）医疗器械有限公司 一种可生物降解的栓塞微球及其制备方法和应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3003986A (en) * 1956-07-06 1961-10-10 Ici Ltd Process of emulsion polymerization of ethylenically unsaturated monomers utilizing taylor ring flow pattern
US3797485A (en) * 1971-03-26 1974-03-19 Alza Corp Novel drug delivery device for administering drug into blood circulation in blood vessel
JPS6020934B2 (ja) 1980-12-20 1985-05-24 クロイ電機株式会社 タイマ−回路
US4622362A (en) * 1981-03-30 1986-11-11 California Institute Of Technology Polyacrolein microspheres
US4413070A (en) * 1981-03-30 1983-11-01 California Institute Of Technology Polyacrolein microspheres
JPS6049016B2 (ja) * 1981-08-19 1985-10-30 日本ランズバ−グ株式会社 乳化液の製造方法及びその装置
US4480078A (en) * 1981-09-23 1984-10-30 The Goodyear Tire & Rubber Company Continuous emulsion polymerization process
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
JPS60215365A (ja) 1984-04-11 1985-10-28 東宝薬品工業株式会社 真球ゼラチン粒またはゼラチンマイクロカプセル等の製造方法およびその装置
CA1277797C (en) * 1984-04-19 1990-12-11 You-Ling Fan Process for the polymerization of shear-stable water- in-oil emulsions
JPS61293911A (ja) * 1985-06-24 1986-12-24 Teisan Seiyaku Kk 徐放化製剤
JPS62148501A (ja) * 1985-12-23 1987-07-02 Sumitomo Chem Co Ltd 光学材料用重合体の製造方法
JPS62169723A (ja) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk 徐放化製剤
DE69133205T2 (de) 1990-10-19 2003-12-11 New York University, New York Eine methode zur transplantation von zellen in das gehirn und ihre therapeutische verwendung
CA2102605A1 (en) 1991-05-23 1992-11-24 Evan C. Unger Liposoluble compounds for magnetic resonance imaging
FR2676927B1 (fr) * 1991-05-29 1995-06-23 Ibf Microspheres utilisables pour les occlusions vasculaires therapeutiques et solutions injectables les contenant.
US5281968A (en) * 1991-09-06 1994-01-25 Nec Corporation DC offset correction circuit for A/D converter
JP3166320B2 (ja) 1992-07-01 2001-05-14 富士通株式会社 レジスト塗膜の異物検査方法及び装置
IL115728A0 (en) 1994-10-25 1996-01-19 Boehringer Mannheim Gmbh Biomaterial containing epithelial cells and use thereof as a transplant
US6538026B1 (en) * 1997-09-11 2003-03-25 Provasis Therapeutics, Inc. Compositions useful for remodeling body spaces
EP1059943B1 (en) 1998-03-06 2004-12-01 Biosepra Medical Inc. Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
JP2001062273A (ja) * 1999-08-27 2001-03-13 Dow Corning Toray Silicone Co Ltd 連続混合装置
EP1656957B1 (en) * 2000-03-20 2015-06-03 Biosphere Medical, Inc. Injectable microspheres for tissue construction
US7338657B2 (en) * 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
EP1274472A2 (en) * 2000-03-20 2003-01-15 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
DE01918975T1 (de) 2000-03-24 2006-04-13 Biosphere Medical, Inc., Rockland Mikrokügelchen zur aktiven Embolisierung
JP2001294603A (ja) * 2000-04-12 2001-10-23 Mitsubishi Chemicals Corp 半回分式乳化重合プロセスによるポリマー粒子の製造方法
FR2815036A1 (fr) 2000-10-05 2002-04-12 Atofina Procede pour augmenter la masse molaire d'un copolymere cationique de chlorure d'acryloyloxyethyltrimethylammonium, et copolymeres correspondants
WO2002041987A2 (en) * 2000-10-25 2002-05-30 Tufts University Polymeric microspheres
JP2002128805A (ja) * 2000-10-31 2002-05-09 Kanegafuchi Chem Ind Co Ltd 分散液の作成方法及び塩化ビニル系ペースト樹脂の製造方法
US7232691B2 (en) * 2001-11-27 2007-06-19 Los Alamos National Security, Llc Bioassay and biomolecular identification, sorting, and collection methods using magnetic microspheres
US7449236B2 (en) * 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
JP3957603B2 (ja) * 2002-09-27 2007-08-15 株式会社カネカ イソブチレン系熱可塑性エラストマーの製造方法
DE10301874A1 (de) * 2003-01-17 2004-07-29 Celanese Emulsions Gmbh Verfahren und Vorrichtung zur Herstellung von Emulsionspolymerisaten
US7152550B2 (en) * 2005-01-06 2006-12-26 Ralph Walker Automatic animal feeding and water providing apparatus
JP4812381B2 (ja) * 2005-09-15 2011-11-09 日産自動車株式会社 金属基カーボンナノチューブ複合材料の製造方法
WO2009148058A1 (ja) * 2008-06-02 2009-12-10 株式会社カネカ 固体脂を使ったマイクロカプセルの製造方法
EP2351779B1 (en) * 2010-01-27 2019-04-24 Biosphere Medical, Inc. Microspheres and method of making the microspheres
JP6020934B2 (ja) 2011-08-05 2016-11-02 パナソニックＩｐマネジメント株式会社 画像処理装置

Also Published As

Publication number Publication date
KR20110119612A (ko) 2011-11-02
US10022469B2 (en) 2018-07-17
BRPI1100013B1 (pt) 2020-10-13
JP2014208837A (ja) 2014-11-06
JP2018138659A (ja) 2018-09-06
CN102232098A (zh) 2011-11-02
US20160361458A1 (en) 2016-12-15
US20130252900A1 (en) 2013-09-26
WO2011092196A1 (en) 2011-08-04
US20110182998A1 (en) 2011-07-28
KR101297500B1 (ko) 2013-08-20
EP2351779B1 (en) 2019-04-24
EP2351779A1 (en) 2011-08-03
JP2017020027A (ja) 2017-01-26
US9439861B2 (en) 2016-09-13
JP2012511055A (ja) 2012-05-17
JP6484591B2 (ja) 2019-03-13
CN102232098B (zh) 2015-04-01

Similar Documents

Publication Publication Date Title
BRPI1100013A2 (pt) microesfera, métodos de preparar microesferas, de embolização em um paciente, e de gerenciar ou tratar uma doença dependente da angiogênese em um paciente
CY2020020I1 (el) Κυκλικα παραγωγα εστερων βορονικου οξεος, μεθοδος για την παρασκευη και θεραπευτικες χρησεις αυτων
IL264200B (en) Flexible cushioning pads, items incorporating such pads, and methods of making and using
BRPI1106075A2 (pt) máquina de jogos, método para operar uma máquina de jogos, e, sistema para jogos sem dinheiro em espécie
BR112013012198A2 (pt) cateter, sistema de formação de imagem médica e produto de programa de computador
EP2593001A4 (en) NONINVASIVE MONITORING OF PHYSIOLOGICAL DISORDER
PL2621523T3 (pl) Sposoby leczenia choroby autoimmunologicznej z zastosowaniem biokompatybilnych bioabsorbowalnych nanosfer
EP2489027A4 (en) PHYSIOLOGY-SIMULATING CLOTHING PIECE AND SYSTEMS AND METHOD THEREFOR
BR112013014674A2 (pt) sistema, estetoscópio e método para indicação de risco de doença da artéria coronária
PT2590976E (pt) Derivados da imidazopiridina, seu processo de preparação e sua utilização terapêutica
BR112014009634A2 (pt) preparação e agente terapêutico
IL223215B (en) Nanowire catalsyts and methods of producing the same
PT2616087T (pt) Fagos antibacterianos, péptidos fágicos e métodos de utilização dos mesmos
BRPI1004899A2 (pt) composto, composição farmacêutica, método para tratar uma doença ou distúrbio relacionado a pi3k em um indivíduo necessitando do mesmo, método para tratar uma doença mediada por mtor, método para tratar ambas as doenças mediadas por pi3k e hdac
EP2621404A4 (en) SYSTEMS AND METHOD FOR MULTILAYER FABRICS
BR112013013311A2 (pt) agente terapêutico de indução de citotoxicidade
DK2539015T3 (da) Nethindeprotese
BR112013018469A2 (pt) dispositivos e métodos para tratamento de tecidos
EP2890440A4 (en) DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DISEASES
EP2601633A4 (en) SYSTEMS AND METHODS OF USE OF PHYSIOLOGICAL INFORMATION
BR112013009294A2 (pt) componente dental, fixação dental, conjunto de implante dental e sistema de implante dental
FR2966718B1 (fr) Implant de laminoplastie, notamment cervicale
EP2553639A4 (en) SYSTEMS AND METHODS FOR MANAGING THE TREATMENT OF ORPHAN DISEASE
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
PT2611844E (pt) Produção e utilização de polímeros de emulsão aquosa

Legal Events

Date Code Title Description
B15L Others concerning applications: renumbering

Free format text: RENUMERADO O PEDIDO DE PI1100013-9 PARA PP1100013-9.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/01/2011, OBSERVADAS AS CONDICOES LEGAIS.